ECT2 and head and neck squamous cell carcinoma: Documentation of new molecules such as ECT2 and PLAC8, not extensively reported in HNSCC previously, further indicates that the meta-analysis based approach can enable identification of novel candidate biomarkers and therapeutic targets.